MK-1966

MK-1966 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-1966, covering 2019-02-04 to 2019-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Dose Evaluation of MK-1966 in Combination With SD-101 in Participants With Advanced Malignancies (MK-1966-001) [Phase 1]

See pricing